Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Libman-Sacks Disease

pyrrolidine dithiocarbamate has been researched along with Libman-Sacks Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cao, HY; Li, D; Li, HB; Lu, HX; Sun, J; Wang, YP1
Ding, SS; Feng, YJ; Wang, XH; Ye, DQ; Zhai, JX; Zhang, ZX; Zou, LW1

Other Studies

2 other study(ies) available for pyrrolidine dithiocarbamate and Libman-Sacks Disease

ArticleYear
The protection of NF-κB inhibition on kidney injury of systemic lupus erythematosus mice may be correlated with lncRNA TUG1.
    The Kaohsiung journal of medical sciences, 2020, Volume: 36, Issue:5

    Topics: Animals; Complement C3; Female; Immunoglobulin G; Inflammation Mediators; Kidney; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; NF-kappa B; Pyrrolidines; RNA, Long Noncoding; Thiocarbamates

2020
PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
    Molecular biology reports, 2012, Volume: 39, Issue:6

    Topics: Animals; Antibodies, Antinuclear; Antioxidants; Chemokine CCL2; Female; Gene Expression; Gene Expression Regulation; Glomerulonephritis, Membranoproliferative; Kidney; Lipopolysaccharides; Lupus Erythematosus, Systemic; MAP Kinase Signaling System; Mice; Mice, Inbred MRL lpr; Mitogen-Activated Protein Kinases; Phosphorylation; Proteinuria; Pyrrolidines; Renal Insufficiency; Thiocarbamates; Transcription Factor RelA

2012